The molecular blueprint of targeted radionuclide therapy
(si apre in una nuova finestra)
Autori:
Irina Primac, Kevin Tabury, Alpaslan Tasdogan, Sarah Baatout, Ken Herrmann
Pubblicato in:
Nature Reviews Clinical Oncology, Numero 22, 2025, ISSN 1759-4774
Editore:
Springer Science and Business Media LLC
DOI:
10.1038/S41571-025-01069-Z
Head-to-head comparison of fibroblast activation protein inhibitors (FAPI) radiopharmaceuticals and [18F]FDG in gynaecological malignancies: systematic literature review and meta-analysis
(si apre in una nuova finestra)
Autori:
Anita Florit, Elizabeth J. de Koster, Serena Sassano, Lejla Alic, Giusi Pisano, Floris H. P. van Velden, Salvatore Annunziata, Irina Primac, Maria Rosaria Ruggiero, Cristina Müller, Evis Sala, Wolfgang P. Fendler, Giovanni Scambia, Lioe-Fee de Geus-Oei, Anna Fagotti, Vittoria Rufini, Angela Collarino
Pubblicato in:
European Journal of Nuclear Medicine and Molecular Imaging, Numero 52, 2025, ISSN 1619-7070
Editore:
Springer Science and Business Media LLC
DOI:
10.1007/S00259-025-07277-0